Oncology and Hematology
17-32 of 246
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
- MinuteCE®
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
0.50 program creditsNeal Ready, MD, PhD
Sara A. Hurvitz, MD, FACP
Tiffany Traina, MD
Ticiana Leal, MD
- MinuteCE®
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
0.50 program creditsNeal Ready, MD, PhD
Neal Ready, MD, PhD
Ticiana Leal, MD
- MinuteCE®
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
0.50 program creditsTiciana Leal, MD
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- MinuteCE®
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- MinuteCE®
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
